News

There is an ever increasing number of families caring for an aged loved one living independently or in their own homes. Unfortunately, the need to be at work to pay the bills and the requirements of running a home and family usually makes...

A life sciences company based on Indiana University technology has received a two-year, $1,472,476 grant from the National Institutes of Health to help researchers determine if nerve activity is associated with a common heart rhythm...

Higher education is associated with a reduced risk of developing heart failure after a heart attack, reports a study in more than 70 000 patients published  in the European Journal of Preventive Cardiology.1 “Heart failure is a serious...

Transgenomic, Inc. (TBIO) announced that it has signed a commercial license agreement with Laboratory Corporation of America® Holdings (LabCorp®) for TBIO’s portfolio of intellectual property pertaining to DNA susceptibility testing for Long...

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced that 500 patients have received the company’s Parachute® Ventricular Partitioning Device for heart failure. Patients have been...

InfoBionic, Inc. announced that BioTelemetry, Inc. and InfoBionic agreed to dispose of BioTelemetry's obsolete claims of patent infringement against a first-generation device. InfoBionic is pleased to offer its state-of-the-art, FDA-cleared...

Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced that the University of Chicago Medicine will implement the Company’s Niobe® ES remote magnetic navigation system as part of its...

St. Jude Medical, Inc., a global medical device company, announced Food and Drug Administration (FDA) approval and the launch of SyncAV™ CRT software, designed to build upon the company’s first-to-market MultiPoint™ Pacing technology and...

Highlights: Ultra-short acting and highly cardio-selective beta blocker Rapibloc® (Landiolol) receives regulatory approval in Europe. Rapibloc® (Landiolol) allows rapid control of heart rate with a straightforward dosing scheme in a...

First pediatric institution in U.S. to offer magnetic navigation technology for cardiac ablation Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced that Texas Children’s Hospital...